Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Impact of Introducing Basaglar, a Long-acting Analog Insulin, on Clinical and Quality of Life Outcomes in Youth With Diabetes in Pakistan

NCT06717191 is registered in ClinicalTrials.gov with Life for a Child Program, Diabetes Australia as lead sponsor.

NCT NCT06717191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06717191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Impact of Introducing Basaglar, a Long-acting Analog Insulin, on Clinical and Quality of Life Outcomes in Youth With Diabetes in Pakistan
Lead sponsor
Life for a Child Program, Diabetes Australia
Phase
Phase 4
Overall status
Completed
Start date
June 9, 2022
Completion date
August 2, 2024
Enrollment
296 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes